The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Revolutionizing Recovery: How Dr. Lundquist is Using BPC 157, TB 500, and Regenerative Therapies to Accelerate Healing Active Life Pain Center BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University